Sepsis in patients with haematological versus solid cancer: a retrospective cohort study

Objectives This study aims to examine the outcome of haematological and patients with solid cancer presenting with sepsis to the emergency department (ED).Design Single-centred, retrospective cohort study. Setting conducted at an academic emergency department of a tertiary hospital.Participants All...

Full description

Saved in:
Bibliographic Details
Main Authors: Hani Tamim, Maha Makki, Sarah Jamali, Ralphe Bou Chebl, Rawan Safa, Mohammad Sabra, Ali Chami, Iskandar Berbari, Gilbert Abou Dagher
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/2/e038349.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850215042468806656
author Hani Tamim
Maha Makki
Sarah Jamali
Ralphe Bou Chebl
Rawan Safa
Mohammad Sabra
Ali Chami
Iskandar Berbari
Gilbert Abou Dagher
author_facet Hani Tamim
Maha Makki
Sarah Jamali
Ralphe Bou Chebl
Rawan Safa
Mohammad Sabra
Ali Chami
Iskandar Berbari
Gilbert Abou Dagher
author_sort Hani Tamim
collection DOAJ
description Objectives This study aims to examine the outcome of haematological and patients with solid cancer presenting with sepsis to the emergency department (ED).Design Single-centred, retrospective cohort study. Setting conducted at an academic emergency department of a tertiary hospital.Participants All patients >18 years of age admitted with sepsis were included.Interventions Patients were stratified into two groups: haematological and solid malignancy.Primary and secondary outcome The primary outcome of the study was in-hospital mortality. Secondary outcomes included intensive care unit (ICU) mortality, ICU and hospital lengths of stay and mechanical ventilation duration.Results 442 sepsis cancer patients were included in the study, of which 305 patients (69%) had solid tumours and 137 patients (31%) had a haematological malignancy. The mean age at presentation was 67.92 (±13.32) and 55.37 (±20.85) (p<0.001) for solid and liquid tumours, respectively. Among patients with solid malignancies, lung cancer was the most common source (15.6%). As for the laboratory workup, septic solid cancer patients were found to have a higher white blood count (12 576.90 vs 9137.23; p=0.026). During their hospital stay, a total of 158 (51.8%) patients with a solid malignancy died compared with 57 (41.6%) patients with a haematological malignancy (p=0.047). There was no statistically significant association between cancer type and hospital mortality (OR 1.15 for liquid cancer p 0.58). There was also no statistically significant difference regarding intravenous fluid administration, vasopressor use, steroid use or intubation.Conclusion Solid tumour patients with sepsis or septic shock are at the same risk of mortality as patients with haematological tumours. However, haematological malignancy patients admitted with sepsis or septic shock have higher rates of bacteraemia.
format Article
id doaj-art-059bffb95b654b1284bc4f78ba91ed5f
institution OA Journals
issn 2044-6055
language English
publishDate 2021-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-059bffb95b654b1284bc4f78ba91ed5f2025-08-20T02:08:43ZengBMJ Publishing GroupBMJ Open2044-60552021-02-0111210.1136/bmjopen-2020-038349Sepsis in patients with haematological versus solid cancer: a retrospective cohort studyHani Tamim0Maha Makki1Sarah Jamali2Ralphe Bou Chebl3Rawan Safa4Mohammad Sabra5Ali Chami6Iskandar Berbari7Gilbert Abou Dagher84Clinical Research Institute, American University of Beirut Medical Center, Beirut, LebanonDepartment of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon1 Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Emergency Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Emergency Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Emergency Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Emergency Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Emergency Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Emergency Medicine, American University of Beirut Medical Center, Beirut, LebanonObjectives This study aims to examine the outcome of haematological and patients with solid cancer presenting with sepsis to the emergency department (ED).Design Single-centred, retrospective cohort study. Setting conducted at an academic emergency department of a tertiary hospital.Participants All patients >18 years of age admitted with sepsis were included.Interventions Patients were stratified into two groups: haematological and solid malignancy.Primary and secondary outcome The primary outcome of the study was in-hospital mortality. Secondary outcomes included intensive care unit (ICU) mortality, ICU and hospital lengths of stay and mechanical ventilation duration.Results 442 sepsis cancer patients were included in the study, of which 305 patients (69%) had solid tumours and 137 patients (31%) had a haematological malignancy. The mean age at presentation was 67.92 (±13.32) and 55.37 (±20.85) (p<0.001) for solid and liquid tumours, respectively. Among patients with solid malignancies, lung cancer was the most common source (15.6%). As for the laboratory workup, septic solid cancer patients were found to have a higher white blood count (12 576.90 vs 9137.23; p=0.026). During their hospital stay, a total of 158 (51.8%) patients with a solid malignancy died compared with 57 (41.6%) patients with a haematological malignancy (p=0.047). There was no statistically significant association between cancer type and hospital mortality (OR 1.15 for liquid cancer p 0.58). There was also no statistically significant difference regarding intravenous fluid administration, vasopressor use, steroid use or intubation.Conclusion Solid tumour patients with sepsis or septic shock are at the same risk of mortality as patients with haematological tumours. However, haematological malignancy patients admitted with sepsis or septic shock have higher rates of bacteraemia.https://bmjopen.bmj.com/content/11/2/e038349.full
spellingShingle Hani Tamim
Maha Makki
Sarah Jamali
Ralphe Bou Chebl
Rawan Safa
Mohammad Sabra
Ali Chami
Iskandar Berbari
Gilbert Abou Dagher
Sepsis in patients with haematological versus solid cancer: a retrospective cohort study
BMJ Open
title Sepsis in patients with haematological versus solid cancer: a retrospective cohort study
title_full Sepsis in patients with haematological versus solid cancer: a retrospective cohort study
title_fullStr Sepsis in patients with haematological versus solid cancer: a retrospective cohort study
title_full_unstemmed Sepsis in patients with haematological versus solid cancer: a retrospective cohort study
title_short Sepsis in patients with haematological versus solid cancer: a retrospective cohort study
title_sort sepsis in patients with haematological versus solid cancer a retrospective cohort study
url https://bmjopen.bmj.com/content/11/2/e038349.full
work_keys_str_mv AT hanitamim sepsisinpatientswithhaematologicalversussolidcanceraretrospectivecohortstudy
AT mahamakki sepsisinpatientswithhaematologicalversussolidcanceraretrospectivecohortstudy
AT sarahjamali sepsisinpatientswithhaematologicalversussolidcanceraretrospectivecohortstudy
AT ralphebouchebl sepsisinpatientswithhaematologicalversussolidcanceraretrospectivecohortstudy
AT rawansafa sepsisinpatientswithhaematologicalversussolidcanceraretrospectivecohortstudy
AT mohammadsabra sepsisinpatientswithhaematologicalversussolidcanceraretrospectivecohortstudy
AT alichami sepsisinpatientswithhaematologicalversussolidcanceraretrospectivecohortstudy
AT iskandarberbari sepsisinpatientswithhaematologicalversussolidcanceraretrospectivecohortstudy
AT gilbertaboudagher sepsisinpatientswithhaematologicalversussolidcanceraretrospectivecohortstudy